Healios KK (HLOSF)
2.10
+0.17
(+8.81%)
USD |
OTCM |
Jan 16, 16:00
Healios EPS Diluted (Quarterly): 0.0331 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | -0.0253 |
| Nxera Pharma Co., Ltd. | -0.1253 |
| PeptiDream Inc. | -0.0575 |
| Stemcell Holdings, Inc. | -- |
| AnGes, Inc. | -0.0127 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 3.811M |
| Revenue (Quarterly) | 0.1288M |
| Total Expenses (Quarterly) | -3.689M |
| Enterprise Value | 216.30M |
| Gross Profit Margin (Quarterly) | -494.9% |
| Earnings Yield | -12.58% |
| Normalized Earnings Yield | -12.58 |